| P50 | author | Konrad Pesudovs | Q37393333 |
| | Jill Keeffe | Q58491619 |
| | Ecosse L Lamoureux | Q75156305 |
| P2093 | author name string | Alan Tennant | |
| | Julie F Pallant | |
| | Gwyn Rees | |
| | Patricia M O'Connor | |
| P2860 | cites work | +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life | Q24803944 |
| | Ranibizumab for neovascular age-related macular degeneration | Q29617549 |
| | Patient-centred measurement in ophthalmology--a paradigm shift | Q33246797 |
| | Age-related macular degeneration--emerging pathogenetic and therapeutic concepts | Q33263472 |
| | Development of the 25-item National Eye Institute Visual Function Questionnaire | Q34083677 |
| | A vision specific functional index for use in patients with age related macular degeneration. | Q35307622 |
| | Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society | Q35589826 |
| | Impact of age related macular degeneration on quality of life | Q35761765 |
| | Comparative fit indexes in structural models | Q39513145 |
| | Vision and mobility performance of subjects with age-related macular degeneration | Q40618054 |
| | Likert or Rasch? Nothing is more applicable than good theory | Q40634676 |
| | Neuroticism predicts depression and disability in age-related macular degeneration | Q44567759 |
| | Pegaptanib for neovascular age-related macular degeneration | Q45206481 |
| | The psychosocial impact of macular degeneration. | Q45994687 |
| | Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study | Q46948681 |
| | Comparing alternative Rasch-based methods vs raw scores in measuring change in health | Q47282437 |
| | The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis | Q47807440 |
| | The Quality of Life Impact of Refractive Correction (QIRC) Questionnaire: development and validation. | Q51578035 |
| | Application of Rasch analysis in the development and application of quality of life instruments. | Q52858735 |
| | Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma? | Q53180558 |
| | Impact of cataract surgery on quality of life in patients with early age-related macular degeneration. | Q53180570 |
| | The effectiveness of low-vision rehabilitation on participation in daily living and quality of life. | Q53199272 |
| | The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis. | Q53221118 |
| | Development of a questionnaire for measurement of vision-related quality of life. | Q53559921 |
| | Associations of visual function with physical outcomes and limitations 5 years later in an older population | Q57232784 |
| | The Impact of Vision Impairment Questionnaire: An Assessment of Its Domain Structure Using Confirmatory Factor Analysis and Rasch Analysis | Q57244104 |
| | The Refractive Status and Vision Profile: Evaluation of psychometric properties and comparison of Rasch and summated Likert-scaling | Q57244115 |
| | The VF-14 | Q58760439 |
| P433 | issue | 2 | |
| P921 | main subject | age related macular degeneration | Q830308 |
| P304 | page(s) | 105-113 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Ophthalmic Epidemiology | Q15759084 |
| P1476 | title | Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale | |
| P478 | volume | 15 | |